Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Socrates E Papapoulos

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2017
Impact Microindentation: Consistency of Serial Measurements and Alterations in Patients With Paget's Disease of the TibiaFrank Malgo, Neveen At Hamdy, Socrates E Papapoulos, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2008
Normal growth and muscle dysfunction in X-linked hypophosphatemic rickets associated with a novel mutation in the PHEX genePolyzois Makras, Neveen A T Hamdy, Sarina G Kant, et al.
The Journal of Clinical Endocrinology and Metabolism|March 14, 2015
Bone material strength as measured by microindentation in vivo is decreased in patients with fragility fractures independently of bone mineral densityFrank Malgo, Neveen A T Hamdy, Socrates E Papapoulos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 16, 2010
Glucocorticoids are not always deleterious for boneAntoon H J M van Lierop, Neveen A T Hamdy, Socrates E Papapoulos
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2025
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trialPolyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
European Journal of Endocrinology|October 11, 2011
Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?Janneke E Witteveen, Antoon H van Lierop, Socrates E Papapoulos, et al.
Bone Reports|February 20, 2026
Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosisAthanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, et al.
Bone|June 14, 2020
The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosisPolyzois Makras, Socrates E Papapoulos, Stergios A Polyzos, et al.
Bone|July 1, 2020
Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorptionAndrea Giusti, Dario Camellino, Daniele Saverino, et al.
Cytokine & Growth Factor Reviews|May 5, 2005
SOST/sclerostin, an osteocyte-derived negative regulator of bone formationRutger L van Bezooijen, Peter ten Dijke, Socrates E Papapoulos, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 18, 2017
Impact Microindentation: Consistency of Serial Measurements and Alterations in Patients With Paget's Disease of the TibiaFrank Malgo, Neveen At Hamdy, Socrates E Papapoulos, et al.
The Journal of Clinical Endocrinology and Metabolism|February 7, 2008
Normal growth and muscle dysfunction in X-linked hypophosphatemic rickets associated with a novel mutation in the PHEX genePolyzois Makras, Neveen A T Hamdy, Sarina G Kant, et al.
The Journal of Clinical Endocrinology and Metabolism|March 14, 2015
Bone material strength as measured by microindentation in vivo is decreased in patients with fragility fractures independently of bone mineral densityFrank Malgo, Neveen A T Hamdy, Socrates E Papapoulos, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 16, 2010
Glucocorticoids are not always deleterious for boneAntoon H J M van Lierop, Neveen A T Hamdy, Socrates E Papapoulos
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 26, 2025
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trialPolyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, et al.
European Journal of Endocrinology|October 11, 2011
Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?Janneke E Witteveen, Antoon H van Lierop, Socrates E Papapoulos, et al.
Bone Reports|February 20, 2026
Successful management of denosumab discontinuation in a patient with primary pediatric osteoporosisAthanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, et al.
Bone|June 14, 2020
The three-year effect of a single zoledronate infusion on bone mineral density and bone turnover markers following denosumab discontinuation in women with postmenopausal osteoporosisPolyzois Makras, Socrates E Papapoulos, Stergios A Polyzos, et al.
Bone|July 1, 2020
Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorptionAndrea Giusti, Dario Camellino, Daniele Saverino, et al.
Cytokine & Growth Factor Reviews|May 5, 2005
SOST/sclerostin, an osteocyte-derived negative regulator of bone formationRutger L van Bezooijen, Peter ten Dijke, Socrates E Papapoulos, et al.
Pageof 8